Emcure Pharma share price hit the 10 percent upper circuit on Thursday after it reported 64 percent jump in its consolidated net profit for the March quarter of 2025.
Shares of Emcure Pharmaceuticals Ltd rose to 1,180.9 per share on the NSE, up 10 percent on the back of strong Q4 numbers. The stock has been gaining for the last two days.
The company reported a 64.4 percent year-on-year (YoY) increase in net profit, which rose to Rs 189 crore in the fourth quarter of FY25, up from Rs 115 crore in the same period last year.
The company's revenue also posted a strong growth of 19.5 percent YoY, climbing to Rs 2,116 crore, compared to Rs 1,771.3 crore in Q4FY24, reflecting sustained demand across key markets.
The company also recommended a dividend for the financial year ended March 31, 2025. In an exchange filing, the company said, "The board of directors of the company at its meeting held today i.e. Thursday, May 22, 2025, has approved/ recommended a final dividend of Rs 3 per equity share of Rs 10 each of the company (at the rate of 30%) for the financial year ended March 31, 2025."
The company's total income rose to Rs 2,121 crore for the quarter under review, against Rs 1,784 crore in the year ago period. The expenses of the company also rose to Rs 1,850 crore in Q4FY25, compared to Rs 1,617 crore in Q4FY24.
Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
